The National Comprehensive Cancer Network (NCCN) recommends that the COVID-19 vaccine should be given to cancer patients and survivors. Cancer patients and survivors should be included in priority group one and immunized as soon as the vaccine is available, with a few exceptions.
The authorities have jointly agreed that patients on active cancer treatment are at a higher risk of COVID-19 infection and complications. Hence, there is a necessity to prioritize patients with cancer for the COVID-19 vaccine. Patients with cancer require a highly efficacious vaccine to protect their lives. The Pfizer-BioNTech vaccine and Moderna vaccine are around 90% to 95% effective in patients with normal immunity, although we have no idea how effective they will be in those with cancer and cancer survivors.
Some of the guidance for the COVID-19 vaccine for patients with cancer includes:
- Patients with active cancer on treatment, those planning to start the treatment, and cancer survivors should be given the vaccine on priority when it is available.
- Although there are limited data on the safety and efficacy of the COVID-19 vaccine, patients with cancer should be given priority, especially because both vaccines are not live vaccines (don’t contain the weakened form of the coronavirus).
- Vaccination should be delayed in patients with cancer for the following reasons:
- Recent exposure to the COVID-19 virus
- Very high anti-COVID antibody titers
- Hematopoietic stem cell transplantation
- Engineered cellular therapy
- Simultaneous pregnancy
- Age younger than 16 years
- Additionally, caregivers of patients with cancer should be immunized early.
- While giving vaccination to patients with cancer, additional risk factors associated with the patients should also be taken into account, which includes:
- Age
- Comorbidities
- Social and demographic factors
The below table presents the COVID-19 vaccine recommendations for patients with cancer.
Patients Treatment/Cancer Type | Timing |
| Hematopoietic cell transplantation (HCT)/Cellular therapy | |
| At least 3 months post-HCT/cellular therapy |
| Hematologic malignancies | |
| Receiving intensive cytotoxic chemotherapy (cytarabine/anthracycline-based induction regimens for acute myeloid leukemia [AML]) | Delay until absolute neutrophil count (ANC) increases to normal |
| Marrow failure from disease and/or therapy expected to have limited or no recovery | When the vaccine is available |
| Long-term maintenance therapy (targeted agents for chronic lymphocytic leukemia or myeloproliferative neoplasms [MPN]) | When the vaccine is available |
| Solid tumor malignancies | |
| Receiving cytotoxic chemotherapy | When the vaccine is available |
| Targeted therapy | When the vaccine is available |
| Checkpoint inhibitors and other immunotherapy | When the vaccine is available |
| Radiation | When the vaccine is available |
| Major surgery | Separate date of surgery from immunization by at least a few days |
| Caregivers and household/Close contacts (≥16 years of age) | When the vaccine is available/whenever they are eligible. |
If there is a limited supply of vaccines, prioritizing among patients with cancer is necessary. The following criteria can be considered while selecting patients with cancer:
- Prioritize patients who are on active cancer treatment, those planning to start treatment, and those immediately post-treatment (<6 months)
- Additional risk factors that need consideration include:
- Patients with advanced age (≥65 years of age)
- Patients with comorbidities (chronic pulmonary, cardiovascular, or renal disease)
- Social and demographic factors, which include:
- Poverty
- Limited access to healthcare
- Underrepresented minorities
Which COVID-19 vaccines are available?
As of now, two COVID-19 vaccines are available in the United States:
- The Pfizer-BioNTech vaccine is authorized for people who are 16 years of age or older. It is given in two doses 3 weeks apart.
- The Moderna vaccine is authorized for people who are 18 years of age or older. It is given in two doses 4 weeks apart.
Both the vaccines comprise messenger RNA (mRNA), which is a COVID-19 virus genetic material. The mRNA prompts the body cells to make copies of the virus’s spike protein. When the replicas of spike proteins are made, it triggers the immune system to learn to act against the virus if the body is exposed in the future.
Should cancer patients and survivors get the vaccine?
The answer is yes. Except for people with certain risk factors mentioned in the table above, COVID-19 vaccines should be prioritized in patients with cancer and cancer survivors. Current COVID-19 vaccines available in the United States do not contain live viruses; hence, they can be given to patients with cancer and cancer survivors.
SLIDESHOW
Skin Cancer Symptoms, Types, Images See Slideshowhttps://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/low-blood-counts/infections/covid-19-vaccines-in-people-with-cancer.html
Top Guide for COVID-19 Vaccine for Cancer Patients Related Articles
Adult Soft Tissue Sarcoma
Soft tissue sarcoma is a rare type of cancer that forms in the soft tissues of the body. Soft tissues include the muscle, tendons, fat, lymph, blood vessels, and nerves. Sarcomas can appear anywhere in the body but are usually encountered in the arms, legs, chest, abdomen, head, and neck. Although the condition primarily affects adults, it can rarely affect children.
Blood Cancer Types
Types of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may include fever, night sweats, fatigue, and other symptoms. Blood cancer treatment depends on the type of cancer and other factors. Blood tests for cancer as well as imaging tests and needle biopsy may help diagnose the condition.
Can Diarrhea Be an Initial Symptom of COVID-19?
COVID-19 has become a common illness that affects many people. Learn the signs of COVID-19, what causes it, how doctors diagnose it, and what you can do to treat it.
Cancer
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Cancer 101 Slideshow
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read about the common type of cancers.
Colon Cancer Prevention
Colorectal cancer is both curable and preventable if it is detected early and completely removed before the cancerous cells metastasize to other parts of the body. Colonoscopy and flexible sigmoidoscopy (along with digital rectal examination and stool occult blood testing) are both effective at preventing colo-rectal cancers and detecting early colo-rectal cancers.
Coronavirus COVID-19 Prevention: Test Your Medical IQ
What's really the best way to prevent the spread of new coronavirus COVID-19? Should wear a mask or not? Take this quiz to find out!
COVID-19 Vaccine Myths and Facts Quiz
The FDA has granted Emergency Use Authorizations for COVID-19 vaccines that have been shown to be safe and effective as established by data from large clinical trials.
How Do the COVID-19 Coronavirus Tests Work?
Tests used for detection of SARS-CoV-2 (COVID-19) may use two methods to detect SARS-CoV-2 virus, the cause of COVID-19 disease, a debilitating and potentially deadly viral pneumonia. Genomic or molecular detection confirms the presence of viral DNA. The immunoglobulin or serology tests can tell whether or not you have been exposed to coronavirus, but not whether you are currently infected. Both tests administered in tandem can give you your complete COVID-19 infection status.
Cancer: Symptoms of Common Cancers in Men
Can men get breast cancer? Cancer symptoms men need to watch out for include skin changes, difficulty swallowing, rapid weight loss, a breast mass, and more. Learn possible clues to finding and detecting cancer early.
What Is Microsporidiosis?
Microsporidiosis is an infection caused by the microsporidia parasite. The disease is uncommon in people with normal immune systems. Symptoms in people with immune deficiency include diarrhea, malabsorption, gallbladder disease, cough, labored breathing, urinary tract infection, bowel perforation and keratoconjunctivitis. Microsporidiosis treatment depends on the site of infection and the species of microsporidia involved.
What Are the Most Common Long-Term Effects of COVID-19?
Most people recover from COVID-19 in two weeks. The most common long-term effects of COVID-19 infection are mood problems, neurological issues, heart disease, liver disease, lung disease, and heart disease.
How to Differentiate Between the Signs and Symptoms of COVID-19, Allergies, Cold, and Flu?
Coronavirus disease or COVID-19 is an infectious disease caused by a newly discovered coronavirus called SARS-CoV-2. Most people with COVID-19 will experience a mild to moderate respiratory illness and recover without the need for intensive or special treatment. Serious illness is more likely in elderly people and those with underlying medical conditions such as heart disease, diabetes, chronic respiratory disease, and cancer.
Tests Available for COVID-19
Getting tested for COVID-19 can identify you as a positive or negative patient of the disease. Remember no test is 100% accurate. Different methods of testing have been launched to trace COVID-19 infection.
Signs of Cancer in Women: Symptoms You Can't Ignore
Colon and stomach cancer symptoms can surprise women but can be treated if detected early. Learn about breast cancer signs and symptoms, mammograms, tests for gynecological cancers, and other cancers, including skin cancer, lung cancer, throat cancer, and bladder cancer.
COVID-19 (Coronavirus, 2019-nCoV)
Infection with COVID-19 (2019 novel coronavirus, 2019-nCoV) causes respiratory problems in humans. Transmission of COVID-19 occurs mainly through contact with respiratory sections from an infected person, however, fecal contamination may also spread the virus. Symptoms start off flu-like and progress to coughing, fever, shortness of breath, shaking chills, headache, loss of sense of taste and/or smell, muscle pain, and sore throat. Treatment focuses on supportive care and symptom relief. COVID-19 vaccines are available.